WHO endorses lifestyle changes over GLP-1 drugs in child obesity fight
Tap title to read story
The World Health Organization released global guidelines prioritizing lifestyle changes over weight-loss drugs for childhood obesity. UNICEF data shows obesity has surpassed undernutrition as the leading form of malnutrition in school-aged children globally. For children under ten, the agency recommends diet, exercise, and counseling instead of medication or surgery due to safety uncertainties. Weight-loss drugs may be considered for adolescents aged ten to nineteen after supervised interventions fail. Bariatric surgery remains restricted to mature adolescents with severe obesity after six unsuccessful months of treatment. Officials emphasize that sustainable behavioral change and structural accessibility are essential. About 400 million individuals aged five to nineteen were overweight in 2024, with obesity prevalence quadrupling since 1990. While some pharmaceutical treatments are approved in the United States and the European Union for older adolescents, global health authorities urge caution. Experts state comprehensive support systems must precede medical intervention to effectively combat rising global pediatric obesity rates.